These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1534843

  • 21. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.
    Fanelli RJ, McMonagle-Strucko K.
    Synapse; 1992 Sep; 12(1):75-81. PubMed ID: 1357765
    [Abstract] [Full Text] [Related]

  • 22. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099
    [Abstract] [Full Text] [Related]

  • 23. Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity.
    Knapp DJ, Overstreet DH, Crews FT.
    Brain Res; 1998 Jan 26; 782(1-2):1-10. PubMed ID: 9519243
    [Abstract] [Full Text] [Related]

  • 24. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 26; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 25. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
    Le Saux M, Di Paolo T.
    J Psychiatry Neurosci; 2005 Mar 26; 30(2):110-7. PubMed ID: 15798786
    [Abstract] [Full Text] [Related]

  • 26. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 26; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 27. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
    Adrien J, Lanfumey L, Gozlan H, Fattaccini CM, Hamon M.
    J Pharmacol Exp Ther; 1989 Mar 26; 248(3):1222-30. PubMed ID: 2522986
    [Abstract] [Full Text] [Related]

  • 28. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M.
    J Pharmacol Exp Ther; 1995 Feb 26; 272(2):920-9. PubMed ID: 7853210
    [Abstract] [Full Text] [Related]

  • 29. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB, Miquel MC, Gozlan H, Hamon M.
    J Neurochem; 1991 May 26; 56(5):1705-16. PubMed ID: 1826520
    [Abstract] [Full Text] [Related]

  • 30. Selective irreversible blockade of 5-hydroxytryptamine1A and 5-hydroxytryptamine1C receptor binding sites in the rat brain by 8-MeO-2'-chloro-PAT: a quantitative autoradiographic study.
    Radja F, Daval G, Emerit MB, Gallissot MC, Hamon M, Vergé D.
    Neuroscience; 1989 May 26; 31(3):723-33. PubMed ID: 2531850
    [Abstract] [Full Text] [Related]

  • 31. Acetylcholine receptor targets on cortical pyramidal neurones as targets for Alzheimer's therapy.
    Chessell JP.
    Neurodegeneration; 1996 Dec 26; 5(4):453-9. PubMed ID: 9117562
    [Abstract] [Full Text] [Related]

  • 32. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neuropsychopharmacology; 1996 Nov 26; 15(5):442-55. PubMed ID: 8914117
    [Abstract] [Full Text] [Related]

  • 33. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord.
    Marlier L, Teilhac JR, Cerruti C, Privat A.
    Brain Res; 1991 May 31; 550(1):15-23. PubMed ID: 1832328
    [Abstract] [Full Text] [Related]

  • 34. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA, Peroutka SJ.
    J Neurochem; 1990 Jan 31; 54(1):294-9. PubMed ID: 2136705
    [Abstract] [Full Text] [Related]

  • 35. Neuronotoxicity of axonally transported toxic lectins, abrin, modeccin and volkensin in rat peripheral nervous system.
    Wiley RG, Stirpe F.
    Neuropathol Appl Neurobiol; 1987 Jan 31; 13(1):39-53. PubMed ID: 2437487
    [Abstract] [Full Text] [Related]

  • 36. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A, Mjellem-Jolly N, Hole K.
    Neuropharmacology; 1992 Jan 31; 31(1):25-32. PubMed ID: 1531864
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).
    el Mestikawy S, Cognard C, Gozlan H, Hamon M.
    J Neurochem; 1988 Oct 31; 51(4):1031-40. PubMed ID: 2971097
    [Abstract] [Full Text] [Related]

  • 38. The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine.
    Martin DC, Adams RJ, Aronstam RS.
    Neurochem Res; 1990 Oct 31; 15(10):969-73. PubMed ID: 2150219
    [Abstract] [Full Text] [Related]

  • 39. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat.
    Hedlund P, von Euler G, Fuxe K.
    Brain Res; 1991 Sep 27; 560(1-2):251-9. PubMed ID: 1836971
    [Abstract] [Full Text] [Related]

  • 40. Repeated cocaine administration does not affect 5-HT receptor subtypes (5-HT1A, 5-HT2) in several rat brain regions.
    Javaid JI, Sahni SK, Pandey SC, Davis JM.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):425-9. PubMed ID: 8405113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.